43.84 USD
-0.52 (-1.17%)
43.84 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to VCYT. VCYT was compared to 531 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is growing strongly while it is still valued neutral. This is a good combination! With these ratings, VCYT could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
VCYT had positive earnings in the past year.
In the past year VCYT had a positive cash flow from operations.
In the past 5 years VCYT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of VCYT (2.22%) is better than 89.08% of its industry peers.
VCYT's Return On Equity of 2.41% is amongst the best of the industry. VCYT outperforms 90.21% of its industry peers.
With an excellent Return On Invested Capital value of 2.93%, VCYT belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 6.12%, VCYT belongs to the best of the industry, outperforming 90.02% of the companies in the same industry.
The Operating Margin of VCYT (9.70%) is better than 91.53% of its industry peers.
VCYT has a Gross Margin of 68.53%. This is amongst the best in the industry. VCYT outperforms 80.98% of its industry peers.
In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VCYT has been increased compared to 1 year ago.
The number of shares outstanding for VCYT has been increased compared to 5 years ago.
VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
VCYT has an Altman-Z score of 19.49. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VCYT (19.49) is better than 88.51% of its industry peers.
VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 19.49 |
ROIC/WACC0.33
WACC8.81%
2.3 Liquidity
A Current Ratio of 6.23 indicates that VCYT has no problem at all paying its short term obligations.
The Current ratio of VCYT (6.23) is better than 64.22% of its industry peers.
A Quick Ratio of 5.94 indicates that VCYT has no problem at all paying its short term obligations.
VCYT's Quick ratio of 5.94 is fine compared to the rest of the industry. VCYT outperforms 63.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
3. Growth
3.1 Past
VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
The Revenue has grown by 16.41% in the past year. This is quite good.
VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.93% yearly.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.24% yearly.
VCYT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.54% yearly.
EPS Next Y74.53%
EPS Next 2Y86.75%
EPS Next 3Y59.6%
EPS Next 5Y52.24%
Revenue Next Year14.36%
Revenue Next 2Y12.54%
Revenue Next 3Y12.19%
Revenue Next 5Y11.54%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 115.37, the valuation of VCYT can be described as expensive.
VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 89.45% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.28, VCYT is valued quite expensively.
The Price/Forward Earnings ratio is 41.90, which means the current valuation is very expensive for VCYT.
Based on the Price/Forward Earnings ratio, VCYT is valued cheaply inside the industry as 91.34% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (23.52), we can say VCYT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.37 | ||
| Fwd PE | 41.9 |
4.2 Price Multiples
VCYT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCYT is cheaper than 91.15% of the companies in the same industry.
VCYT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VCYT is cheaper than 93.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.29 | ||
| EV/EBITDA | 43.89 |
4.3 Compensation for Growth
VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VCYT has a very decent profitability rating, which may justify a higher PE ratio.
VCYT's earnings are expected to grow with 59.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)N/A
EPS Next 2Y86.75%
EPS Next 3Y59.6%
5. Dividend
5.1 Amount
VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
43.84
-0.52 (-1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners114.7%
Inst Owner Change3.31%
Ins Owners0.46%
Ins Owner Change-2.17%
Market Cap3.47B
Revenue(TTM)495.14M
Net Income(TTM)30.32M
Analysts82.11
Price Target49.33 (12.52%)
Short Float %6.93%
Short Ratio5.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)14.88%
PT rev (3m)17.32%
EPS NQ rev (1m)8.52%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)31.06%
EPS NY rev (3m)39.68%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)1.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.37 | ||
| Fwd PE | 41.9 | ||
| P/S | 7 | ||
| P/FCF | 35.29 | ||
| P/OCF | 32.01 | ||
| P/B | 2.76 | ||
| P/tB | 8.71 | ||
| EV/EBITDA | 43.89 |
EPS(TTM)0.38
EY0.87%
EPS(NY)1.05
Fwd EY2.39%
FCF(TTM)1.24
FCFY2.83%
OCF(TTM)1.37
OCFY3.12%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.55
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.83% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.87% | ||
| Cap/Sales | 2.03% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.79% | ||
| Profit Quality | 323.94% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 19.49 |
F-Score8
WACC8.81%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y74.53%
EPS Next 2Y86.75%
EPS Next 3Y59.6%
EPS Next 5Y52.24%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.36%
Revenue Next 2Y12.54%
Revenue Next 3Y12.19%
Revenue Next 5Y11.54%
EBIT growth 1Y426.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y47.08%
FCF growth 1Y237.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.75%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status for VCYT stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
How financially healthy is VERACYTE INC?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.
What is the expected EPS growth for VERACYTE INC (VCYT) stock?
The Earnings per Share (EPS) of VERACYTE INC (VCYT) is expected to grow by 74.53% in the next year.